Title(s):
Assistant Professor of Gynecology and Obstetrics
Appointment Phone:
443-997-0400
Primary Location:
Johns Hopkins Outpatient Center
Expertise:
Cervical Cancer, Gynecologic Oncology, Minimally Invasive Surgery, Ovarian Cancer, Robotic Surgery, Uterine Cancer, Uterine Fibroids, Vulvar Cancer
Education and Experience
Training
- University of Alabama at Birmingham (Birmingham AL)/ (2004)
Residencies
- The Johns Hopkins Hospital (Baltimore MD)/ Gynecology/Obstetrics (2008)
Fellowships
- Memorial Sloan - Kettering Cancer Center (New York NY)/ Gynecologic Oncology (2012)
Locations
Johns Hopkins Outpatient Center
601 N. Caroline Street
Baltimore, MD 21287
Phone: 410-955-8240
Appointment Phone: 443-997-0400
Location Map
Johns Hopkins Bayview Medical Center
4940 Eastern Avenue
Baltimore, MD 21224
Phone: 410-955-8240
Appointment Phone: 443-997-0400
Location Map
Department / Division
-
Gynecology and Obstetrics - Gynecologic Oncology
Centers/Institutes
Centers / Institutes
- Kelly Gynecologic Oncology Service
- Ovarian Cancer Center
- Sidney Kimmel Comprehensive Cancer Center
Bio
Biography
Edward Tanner, MD, is an assistant professor of gynecologic oncology at the Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center.
His clinical interests include the surgical management of advanced gynecologic cancers as well as minimally invasive surgery for early-stage disease. He has a particular focus on developing innovative techniques for robotic surgery in patients with uterine and cervical cancers.
His research interests include sentinel lymph node mapping in endometrial cancer, exploring ways to reduce complications in patients undergoing surgery for advanced ovarian cancer, as well as identifying new treatments for patients with uterine sarcoma.
A native of Baltimore, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at the Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center where he was one of the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers.
His clinical interests include the surgical management of advanced gynecologic cancers as well as minimally invasive surgery for early-stage disease. He has a particular focus on developing innovative techniques for robotic surgery in patients with uterine and cervical cancers.
His research interests include sentinel lymph node mapping in endometrial cancer, exploring ways to reduce complications in patients undergoing surgery for advanced ovarian cancer, as well as identifying new treatments for patients with uterine sarcoma.
A native of Baltimore, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at the Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center where he was one of the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers.
Awards and Honors
Virginia K. Pearce Award for Best Poster; "Gene Expression Profiling of Advanced Ovarian Cancer to Predict the Need for Maximal Surgical Effort." Society of Memorial Gynecologic Oncologists Annual Meeting; 2009
Excellence in Teaching Award; Johns Hopkins Hospital; 2008
Excellence in Teaching Award; Johns Hopkins Hospital; 2006
Excellence in Teaching Award; Johns Hopkins Hospital; 2008
Excellence in Teaching Award; Johns Hopkins Hospital; 2006
Expertise
- Cervical Cancer
- Gynecologic Oncology
- Minimally Invasive Surgery
- Ovarian Cancer
- Robotic Surgery
- Uterine Cancer
- Uterine Fibroids
- Vulvar Cancer
Research
Research and Publications
Selected publications:
1. Tanner EJ, Zahurak M, Bristow RE, Diaz-Montes TP. Outcomes of Younger Patients with Ovarian Cancer. Gynecol Oncol 2008; 111(2): 221-5. PMID: 18786718.
2. Barlin NJ, Tanner EJ. Ovarian Cancer Screening. Postgraduate Obstetrics and Gynecology. 29 (15), 2009.
3. Tanner EJ, Chi DS, Eisenhauer EL, Diaz-Montes TP, Santillan A, Bristow RE. Early Detection of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: Survival Benefit or Lead Time Bias. Gynecol Oncol 2010; 117(2):336-40. PMID: 20153027.
4. Pant AC, Diaz-Montes TP, Tanner EJ, Ahmad S, Giuntoli RL 2nd, Holloway RW, Bristow RE. Correlation of Extreme Drug Resistance Assay Results and Progression Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. J Chemother 2010; 22(4): 270-4. PMID: 20685633.
5. Shih KK, Qin L-X, Tanner EJ, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat RR, Levine DA. A MicroRNA Survival Signature (MiSS) for Advanced Ovarian Cancer. Gynecol Oncol 2011; 121 (3): 444-50. PMID: 21354599.
6. Tanner EJ, Leitao MM, Garg K, Chi DS, Sonoda Y, Gardner GJ, Barakat RR, Jewell EJ. The Role of Cytoreductive Surgery for Newly Diagnosed Advanced-Stage Uterine Carcinosarcoma. Gynecol Oncol 2011; 123 (3): 548-52. PMID: 21945551.
7. Tanner EJ, Black DR, Zivanovic O, Kehoe SM, Dao F, Konner JA, Barakat RR, Lichtman SM, Levine DA. Patterns of First Recurrence Following Adjuvant Intraperitoneal Chemotherapy for Stage IIIC Ovarian Cancer. Gynecol Oncol 2012; 124 (1): 59-62. PMID: 21982046.
8. Tanner EJ, Long KC, Zhou Q, Brightwell RM, Gardner GJ, Abu-Rustum NR, Leitao MM, Jr., Sonoda Y, Chi DS. Impact of Operative Start Time on Surgical Outcomes in Patients Undergoing Primary Cytoreduction for Advanced Ovarian Cancer. Gynecol Oncol 2012; 126 (1): 58-63. PMID: 22507533.
9. Hyman DM, Long KC, Tanner EJ, Grisham RN, Arnold AG, Bhatia J, Spriggs DR, Soslow RA, Kauff ND, Levine DA. Outcomes of Primary Surgical Cytoreduction in Patients with BRCA-associated High-grade Serous Ovarian Carcinoma. Gynecol Oncol 2012; 126 (2): 224-8. PMID: 22579790.
10. Tanner EJ, Garg K, Leitao MM, Jr., Soslow R, Hensley ML. High Grade Undifferentiated Uterine Sarcoma: Surgery, Treatment, and Survival Outcomes. Gynecol Oncol 2012; 127 (1): 27-31. PMID: 22750260.
11. Tanner EJ, Long KC, Feffer JB, Leitao MM, Jr., Abu-Rustum NR, Barakat RR, Chi DS, Gardner GJ. Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Gynecol Oncol 2012 [Epub ahead of print]. PMID: 23017819.
Selected book chapters:
1. Giuntoli RL II, Tanner EJ. Fallopian Tube Carcinoma. In: Gehrig PA, Secord AA, editors. Handbook of Gynecologic Oncology. Landes Bioscience, Georgetown, TX, 2008.
2. Bristow RE, Tanner EJ. Ovarian Tumors, Borderline Malignancies. In: The 5-Minute OB/GYN Clinical Consult. Lippincott, Williams & Wilkins, Philadelphia, PA, 2008.
3. Tanner EJ, Khoury-Collado F, Chi DS. Cytoreductive Procedures. In: Karlan BY, Bristow RE, Li AJ, editors. Gynecologic Oncology: Clinical Practice and Surgical Atlas, First Edition. McGraw-Hill, New York, NY, 2012 (In Press).
1. Tanner EJ, Zahurak M, Bristow RE, Diaz-Montes TP. Outcomes of Younger Patients with Ovarian Cancer. Gynecol Oncol 2008; 111(2): 221-5. PMID: 18786718.
2. Barlin NJ, Tanner EJ. Ovarian Cancer Screening. Postgraduate Obstetrics and Gynecology. 29 (15), 2009.
3. Tanner EJ, Chi DS, Eisenhauer EL, Diaz-Montes TP, Santillan A, Bristow RE. Early Detection of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: Survival Benefit or Lead Time Bias. Gynecol Oncol 2010; 117(2):336-40. PMID: 20153027.
4. Pant AC, Diaz-Montes TP, Tanner EJ, Ahmad S, Giuntoli RL 2nd, Holloway RW, Bristow RE. Correlation of Extreme Drug Resistance Assay Results and Progression Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. J Chemother 2010; 22(4): 270-4. PMID: 20685633.
5. Shih KK, Qin L-X, Tanner EJ, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat RR, Levine DA. A MicroRNA Survival Signature (MiSS) for Advanced Ovarian Cancer. Gynecol Oncol 2011; 121 (3): 444-50. PMID: 21354599.
6. Tanner EJ, Leitao MM, Garg K, Chi DS, Sonoda Y, Gardner GJ, Barakat RR, Jewell EJ. The Role of Cytoreductive Surgery for Newly Diagnosed Advanced-Stage Uterine Carcinosarcoma. Gynecol Oncol 2011; 123 (3): 548-52. PMID: 21945551.
7. Tanner EJ, Black DR, Zivanovic O, Kehoe SM, Dao F, Konner JA, Barakat RR, Lichtman SM, Levine DA. Patterns of First Recurrence Following Adjuvant Intraperitoneal Chemotherapy for Stage IIIC Ovarian Cancer. Gynecol Oncol 2012; 124 (1): 59-62. PMID: 21982046.
8. Tanner EJ, Long KC, Zhou Q, Brightwell RM, Gardner GJ, Abu-Rustum NR, Leitao MM, Jr., Sonoda Y, Chi DS. Impact of Operative Start Time on Surgical Outcomes in Patients Undergoing Primary Cytoreduction for Advanced Ovarian Cancer. Gynecol Oncol 2012; 126 (1): 58-63. PMID: 22507533.
9. Hyman DM, Long KC, Tanner EJ, Grisham RN, Arnold AG, Bhatia J, Spriggs DR, Soslow RA, Kauff ND, Levine DA. Outcomes of Primary Surgical Cytoreduction in Patients with BRCA-associated High-grade Serous Ovarian Carcinoma. Gynecol Oncol 2012; 126 (2): 224-8. PMID: 22579790.
10. Tanner EJ, Garg K, Leitao MM, Jr., Soslow R, Hensley ML. High Grade Undifferentiated Uterine Sarcoma: Surgery, Treatment, and Survival Outcomes. Gynecol Oncol 2012; 127 (1): 27-31. PMID: 22750260.
11. Tanner EJ, Long KC, Feffer JB, Leitao MM, Jr., Abu-Rustum NR, Barakat RR, Chi DS, Gardner GJ. Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Gynecol Oncol 2012 [Epub ahead of print]. PMID: 23017819.
Selected book chapters:
1. Giuntoli RL II, Tanner EJ. Fallopian Tube Carcinoma. In: Gehrig PA, Secord AA, editors. Handbook of Gynecologic Oncology. Landes Bioscience, Georgetown, TX, 2008.
2. Bristow RE, Tanner EJ. Ovarian Tumors, Borderline Malignancies. In: The 5-Minute OB/GYN Clinical Consult. Lippincott, Williams & Wilkins, Philadelphia, PA, 2008.
3. Tanner EJ, Khoury-Collado F, Chi DS. Cytoreductive Procedures. In: Karlan BY, Bristow RE, Li AJ, editors. Gynecologic Oncology: Clinical Practice and Surgical Atlas, First Edition. McGraw-Hill, New York, NY, 2012 (In Press).
Research Interests
- Robotic and Minimally Invasive Surgery for Gynecologic Cancers
- Management of Uterine Sarcomas
- Surgical Management of Advanced Ovarian Cancer
- Sentinel Lymph Node Mapping of Endometrial Cancer
- Fertility Preservation for Cervical and Endometrial Cancer
More Info
Languages
- English
Memberships
Society of Gynecologic Oncology
Clinical Trials
- National Cancer Institutie
- Gynecologic Oncology Group
Additional Resources
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts